• Arzneimittel Forsch · Feb 1993

    Randomized Controlled Trial Clinical Trial

    [The effect of molecular structure of hydroxyethyl starch on the elimination kinetics and fluidity of blood in human volunteers].

    • F Jung, J Koscielny, C Mrowietz, H Förster, W Schimetta, H Kiesewetter, and E Wenzel.
    • Abteilung für klinische Hämostaseologie und Transfusionsmedizin, Universität des Saarlandes, Homburg/Saar, Osterreich.
    • Arzneimittel Forsch. 1993 Feb 1; 43 (2): 99-105.

    AbstractInfluence of the Molecular Structure of Hydroxyethyl Starch on Elimination Kinetics and Blood Fluidity in Voluntary Subjects In a cross-over study 6 volunteers received an infusion of 500 ml hydroxyethyl starch of a batch with a high C2/C6-substitution ratio (10.8), or after a washout period of 3 months they received a batch with a low C2/C6-substitution ratio (5.8). The infusion solution was administered at random. The batches were identical as regards their physicochemical characteristics (HES 200/0.5 10%). The concentration and molecular weight distribution of the intravascular hydroxyethyl starch molecules were determined after infusion up to 24 h, the blood fluidity before and after infusion. The substitution ratio of the C2- or C6-atoms in the glucose ring has an effect on the degradation of the hydroxyethyl starch molecule: the molecules with a high C2/C6-substitution ratio appear to be degraded within the same period of time, the resulting degradation products, however, have a higher molecular weight. This influences the blood fluidity. While the haematocrit decrease occurring 1 h after end of infusion is comparable, it keeps up for a longer time in case of a higher C2/C6-substitution ratio. The increase of plasma viscosity is more pronounced in case of a high C2/C6-substitution ratio. Clinical consequences are discussed.

      Pubmed     Copy Citation  

      Add institutional full text...

    Notes

    hide…